Xingyu Lv, Yuqi Lin, Xi Zhu, & Xiujun Cai. (2023). Isoalantolactone suppresses gallbladder cancer progression via inhibiting the ERK signalling pathway. Taylor & Francis Group.
Chicago Style (17th ed.) CitationXingyu Lv, Yuqi Lin, Xi Zhu, and Xiujun Cai. Isoalantolactone Suppresses Gallbladder Cancer Progression via Inhibiting the ERK Signalling Pathway. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationXingyu Lv, et al. Isoalantolactone Suppresses Gallbladder Cancer Progression via Inhibiting the ERK Signalling Pathway. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.